Definium Therapeutics DFTX
NASDAQ DFTX
$38.09 +0.09 (+0.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Definium Therapeutics (DFTX) Cash from Investing Activities (2021 - 2026)

Definium Therapeutics (DFTX) posted quarterly Cash from Investing Activities of $42.0 million for Q1 2026, up 125.85% year-over-year from $18.6 million in Q1 2025, and up 20.05% quarter-over-quarter from $35.0 million in Q4 2025.

Analysis

Definium Therapeutics (DFTX) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Definium Therapeutics (DFTX) has reported Cash from Investing Activities for 3 consecutive years, with $42.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 125.85% year-over-year to $42.0 million; the TTM figure through Mar 2026 stood at $52.9 million (up 132.53% YoY), while the FY2025 annual figure was -$151.6 million, changed N/A from the prior year.
  • Cash from Investing Activities advanced to $42.0 million in Q1 2026 per DFTX's latest filing, from $35.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $42.0 million in Q1 2026 and bottomed at -$162.5 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Definium Therapeutics 4.23 Bn 4.23 Bn - -316.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -316.74 Mn
Mar 31, 2026 42.00 Mn
Dec 31, 2025 34.98 Mn
Sep 30, 2025 15.41 Mn
Jun 30, 2025 -39.54 Mn
Mar 31, 2025 -162.46 Mn
Dec 31, 2021 113,000.00
Sep 30, 2021 -27,000.00
Jun 30, 2021 -67,000.00
Mar 31, 2021 -316,000.00